Valneva SE (VALN) Other Operating Expenses (2021 - 2026)
Valneva SE (VALN) posted Other Operating Expenses of $2.3 million for Q1 2026, down 18.27% sequentially from $2.8 million in Q4 2025, and little changed YoY from $2.3 million in Q1 2025.
Analysis
Valneva SE (VALN) Other Operating Expenses (2021 - 2026) Analysis & Trends
Valneva SE has reported Other Operating Expenses for 6 years, with the latest figure at $2.3 million in Q1 2026.
- Quarterly Other Operating Expenses changed 0.35% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.8 million (down 45.29% YoY) and the FY2025 annual result came in at $12.1 million, down 45.98% from the prior year.
- Other Operating Expenses eased to $2.3 million in Q1 2026 per VALN's latest filing, from $2.8 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $11.5 million in Q2 2023 and troughed at $1.6 million in Q2 2022.
- A 5-year average of $4.3 million and a median of $3.7 million in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses tumbled 81.91% in 2022, then surged 610.03% in 2023.
- Over 5 years, Other Operating Expenses stood at $4.8 million in 2022, then grew by 0.39% to $4.8 million in 2023, then grew by 28.36% to $6.2 million in 2024, then slumped by 55.42% to $2.8 million in 2025, then dropped by 18.27% to $2.3 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $2.3 million, $2.8 million, and $4.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Valneva SE | 581.06 Mn | 439.80 Mn | 1.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.17 Mn |
| Mar 31, 2026 | 2.26 Mn |
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 4.05 Mn |
| Jun 30, 2025 | 2.71 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 81.15 Mn |
| Sep 30, 2024 | 9.37 Mn |
| Jun 30, 2024 | 3.70 Mn |
| Mar 31, 2024 | 3.17 Mn |
| Dec 31, 2023 | 4.84 Mn |
| Sep 30, 2023 | 3.27 Mn |
| Jun 30, 2023 | 11.46 Mn |
| Mar 31, 2023 | 3.74 Mn |
| Dec 31, 2022 | 4.82 Mn |
| Sep 30, 2022 | 3.91 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 2.34 Mn |
| Dec 31, 2021 | 7.94 Mn |
| Sep 30, 2021 | 6.66 Mn |